People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

For further information on the guideline development process, please see how we develop NICE guidelines ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

What is the impact of HRT on health outcomes for trans men and non-binary people registered female at birth (who are not taking gender-affirming hormone therapy at the time of taking HRT or in the ...

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

For people with a personal history of breast cancer, or at high familial or genetic risk of breast cancer, does vaginal oestrogen for genitourinary symptoms associated with menopause increase the risk ...

What is the effect of either taking or not taking hormone replacement therapy (HRT) on health outcomes for people experiencing early menopause (aged 40 to 44)? For a short explanation of why the ...